BridgeMD
New treatment option for Rotator Cuff Injuries
Official title Slow and Accelerated Rehabilitation Protocols
ClinicalTrials.gov ID: NCT05450510
What this study is testing
- What it's testing
- Latissimus dorsi transfer is an established treatment option with favorable results in massive, irreparable rotator cuff tears, however, it is controversial if earlier motion is detrimental or beneficial to the postoperative goal of reduced pain and improved clinical outcomes. Therefore, the aim of this study is to compare the effects of slow and accelerated rehabilitation protocols after latissimus dorsi transfer in massive, irreparable rotator cuff tears.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- being in the age range of 18-65 years
- being diagnosed with massive, irreparable rotator cuff tears based on magnetic resonance imaging and clinical continuity tests
- symptoms are unresponsive to conservative care including steroid injections and physiotherapy for at least 6 months
- having a good command of the Turkish language
- scoring above 24 in the Mini Mental State Test
You likely can't join if
- diabetes mellitus
- neurological problems
- cervical disc herniation
- visual, verbal, and/or cognitive defects (aphasia, unilateral neglect, etc.)
- systemic inflammatory problems
- hypermobility, trauma, and/or inflammation that could be a contraindication for mobilization
See the full eligibility criteria
- being in the age range of 18-65 years
- being diagnosed with massive, irreparable rotator cuff tears based on magnetic resonance imaging and clinical continuity tests
- symptoms are unresponsive to conservative care including steroid injections and physiotherapy for at least 6 months
- having a good command of the Turkish language
- scoring above 24 in the Mini Mental State Test
- ≥80% compliance in completing the post-ARCR Phase 1 trainings
- volunteering to participate in the study
- diabetes mellitus
- neurological problems
- cervical disc herniation
- visual, verbal, and/or cognitive defects (aphasia, unilateral neglect, etc.)
- systemic inflammatory problems
- hypermobility, trauma, and/or inflammation that could be a contraindication for mobilization
- former shoulder fractures on the affected side
- advanced glenohumeral arthritis (Hamada grade 3),
- deltoid muscle dysfunction,
- irreparable subscapularis tears,
- active infection,
- shoulder stiffness,
- a history of previous shoulder surgery
The study team makes the final eligibility decision.
Where it's taking place
- Kırşehir, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kırşehir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.